Xilio Development Correlations

XLO Stock

USD 0.64 0.01 1.54%

The current 90-days correlation between Xilio Development and PDS Biotechnology Corp is 0.21 (i.e., Modest diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Xilio Development moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Xilio Development moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Xilio Development Correlation With Market

Modest diversification

The correlation between Xilio Development and DJI is 0.26 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Xilio Development and DJI in the same portfolio, assuming nothing else is changed.

Build AI portfolio with Xilio Stock

Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Xilio Development. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

To learn how to invest in Xilio Stock, please use our How to Invest in Xilio Development guide.

Moving together with Xilio Stock

0.65	VALN	Valneva SE ADR	Pair Corr
0.76	DRMA	Dermata Therapeutics	Pair Corr
0.61	AVH	Avita Medical	Pair Corr
0.86	PYC	Physiomics Plc	Pair Corr
0.62	DTIL	Precision BioSciences Downward Rally	Pair Corr
0.7	VIVS	VivoSim Labs, Symbol Change	Pair Corr
0.71	ALA	Arovella Therapeutics	Pair Corr
0.65	VRAX	Virax Biolabs Group	Pair Corr

Moving against Xilio Stock

0.84	VERA	Vera Therapeutics	Pair Corr
0.84	0P6S	Bayer AG NA	Pair Corr
0.71	DSGN	Design Therapeutics	Pair Corr
0.69	DRUG	Bright Minds Biosciences	Pair Corr
0.65	DNTH	Dianthus Therapeutics	Pair Corr
0.59	DVAX	Dynavax Technologies Trending	Pair Corr
0.54	VCYT	Veracyte	Pair Corr
0.52	DMAC	DiaMedica Therapeutics	Pair Corr
0.51	DXB	Dimerix	Pair Corr
0.49	DRTS	Alpha Tau Medical	Pair Corr
0.48	DNLI	Denali Therapeutics	Pair Corr
0.42	CDIOW	Cardio Diagnostics	Pair Corr
0.35	VKTX	Viking Therapeutics	Pair Corr
0.86	VRTX	Vertex Pharmaceuticals	Pair Corr
0.8	VTVT	vTv Therapeutics	Pair Corr
0.78	VRDN	Viridian Therapeutics	Pair Corr
0.78	ENTA	Enanta Pharmaceuticals	Pair Corr
0.7	VNDA	Vanda Pharmaceuticals Trending	Pair Corr
0.7	VYNE	Vyne Therapeutics	Pair Corr
0.6	ENGN	enGene Holdings Common	Pair Corr
0.36	SRZNW	Surrozen Warrant	Pair Corr

Related Correlations Analysis

	PDSB	ATNM	TPST	OKUR	LVTX	KZR	FGEN	SKYE	TVRD	ALGS
PDSB		0.39	0.53	0.42	0.36	-0.47	0.65	0.24	0.46	0.19	PDSB
ATNM	0.39		0.08	-0.01	0.71	-0.44	0.28	-0.02	0.41	0.63	ATNM
TPST	0.53	0.08		0.25	0.19	-0.56	0.86	0.43	0.43	-0.4	TPST
OKUR	0.42	-0.01	0.25		-0.03	0.17	0.21	0.01	-0.11	-0.05	OKUR
LVTX	0.36	0.71	0.19	-0.03		-0.39	0.43	0.07	0.37	0.52	LVTX
KZR	-0.47	-0.44	-0.56	0.17	-0.39		-0.65	-0.29	-0.86	-0.08	KZR
FGEN	0.65	0.28	0.86	0.21	0.43	-0.65		0.35	0.57	-0.16	FGEN
SKYE	0.24	-0.02	0.43	0.01	0.07	-0.29	0.35		0.29	-0.12	SKYE
TVRD	0.46	0.41	0.43	-0.11	0.37	-0.86	0.57	0.29		0.1	TVRD
ALGS	0.19	0.63	-0.4	-0.05	0.52	-0.08	-0.16	-0.12	0.1		ALGS
	PDSB	ATNM	TPST	OKUR	LVTX	KZR	FGEN	SKYE	TVRD	ALGS

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

FGEN	+ 0.86	TPST
LVTX	+ 0.71	ATNM
FGEN	+ 0.65	PDSB
ALGS	+ 0.63	ATNM
TVRD	+ 0.57	FGEN
TPST	+ 0.53	PDSB

High negative correlations

TVRD	- 0.86	KZR
FGEN	- 0.65	KZR
KZR	- 0.56	TPST
KZR	- 0.47	PDSB
KZR	- 0.44	ATNM
ALGS	- 0.4	TPST

Risk-Adjusted Indicators

There is a big difference between Xilio Stock performing well and Xilio Development Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Xilio Development's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
PDSB	3.56	(0.42)	0.00	(0.12)	0.00	0.00	8.60	(7.14)	27.78
ATNM	3.16	(0.25)	0.00	(0.12)	0.00	0.00	8.05	(5.33)	25.17
TPST	4.61	(1.52)	0.00	(1.26)	0.00	0.00	7.92	(9.56)	60.86
OKUR	4.16	0.17	0.04	0.18	4.50	(4.40)	7.53	(6.92)	23.27
LVTX	1.35	0.24	0.10	(0.59)	1.09	(3.31)	6.25	(2.63)	14.75
KZR	2.27	0.95	0.76	0.79	0.00	(3.10)	6.54	(1.77)	54.12
FGEN	2.49	(0.49)	0.00	(0.47)	0.00	0.00	3.64	(5.28)	28.75
SKYE	5.29	(2.38)	0.00	(1.79)	0.00	0.00	9.02	(10.92)	60.00
TVRD	4.22	(1.61)	0.00	0.89	0.00	0.00	5.61	(6.64)	91.61
ALGS	4.13	(0.06)	(0.01)	0.00	5.11	(3.89)	9.72	(7.62)	25.33

Xilio Development Corporate Management

Martin MD	Pres RD	Profile
Scott Coleman	Chief Officer	Profile
Uli Bialucha	Chief Officer	Profile
Ruth Moulin	Senior Affairs	Profile
Julissa Viana	Vice Communications	Profile
Stacey Davis	Chief Officer	Profile
Christopher Frankenfield	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC